Myomo (MYO) Cash & Equivalents Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | -42.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42.89% |
| Sep 30, 2025 | 79.40% |
| Jun 30, 2025 | 150.00% |
| Mar 31, 2025 | 271.11% |
| Dec 31, 2024 | 260.16% |
| Sep 30, 2024 | 1.24% |
| Jun 30, 2024 | -34.73% |
| Mar 31, 2024 | -41.33% |
| Dec 31, 2023 | 28.53% |
| Sep 30, 2023 | -6.60% |
| Jun 30, 2023 | -12.50% |
| Mar 31, 2023 | -28.43% |
| Dec 31, 2022 | -65.56% |
| Sep 30, 2022 | -41.30% |
| Jun 30, 2022 | -25.68% |
| Mar 31, 2022 | -25.49% |
| Dec 31, 2021 | 26.82% |
| Sep 30, 2021 | -5.34% |
| Jun 30, 2021 | 28.31% |
| Mar 31, 2021 | 26.55% |
| Dec 31, 2020 | 174.13% |
| Sep 30, 2020 | 207.68% |
| Jun 30, 2020 | 60.95% |
| Mar 31, 2020 | 48.66% |
| Dec 31, 2019 | -31.73% |
| Sep 30, 2019 | -52.40% |
| Jun 30, 2019 | -42.92% |
| Mar 31, 2019 | -34.59% |
| Dec 31, 2018 | -49.53% |
| Sep 30, 2018 | 83.41% |
| Jun 30, 2018 | 64.32% |
| Mar 31, 2018 | 1,670.81% |
| Dec 31, 2017 | 1,525.66% |
| Sep 30, 2017 | 905.26% |
| Jun 30, 2017 | 1,003.80% |